Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Selective effects of social anxiety, anxiety sensitivity, and negative affectivity on the neural bases of emotional face processing.

Ball TM, Sullivan S, Flagan T, Hitchcock CA, Simmons A, Paulus MP, Stein MB.

Neuroimage. 2012 Jan 16;59(2):1879-87. doi: 10.1016/j.neuroimage.2011.08.074. Epub 2011 Sep 2.

PMID:
21920442
2.

Neuroticism mediates the relationship between childhood adversity and adult sleep quality.

Ramsawh HJ, Ancoli-Israel S, Sullivan SG, Hitchcock CA, Stein MB.

Behav Sleep Med. 2011;9(3):130-43. doi: 10.1080/15402002.2011.583895.

3.

A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits.

Stein MB, Yang BZ, Chavira DA, Hitchcock CA, Sung SC, Shipon-Blum E, Gelernter J.

Biol Psychiatry. 2011 May 1;69(9):825-31. doi: 10.1016/j.biopsych.2010.11.008. Epub 2010 Dec 30.

4.

Psychometrics of a brief measure of anxiety to detect severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS).

Norman SB, Campbell-Sills L, Hitchcock CA, Sullivan S, Rochlin A, Wilkins KC, Stein MB.

J Psychiatr Res. 2011 Feb;45(2):262-8. doi: 10.1016/j.jpsychires.2010.06.011. Epub 2010 Jul 7.

5.

Recent findings in social phobia among children and adolescents.

Hitchcock CA, Chavira DA, Stein MB.

Isr J Psychiatry Relat Sci. 2009;46(1):34-44. Review.

6.

Selective Mutism Questionnaire: measurement structure and validity.

Letamendi AM, Chavira DA, Hitchcock CA, Roesch SC, Shipon-Blum E, Stein MB.

J Am Acad Child Adolesc Psychiatry. 2008 Oct;47(10):1197-1204. doi: 10.1097/CHI.0b013e3181825a7b.

7.

Combination treatment of invasive fungal infections.

Mukherjee PK, Sheehan DJ, Hitchcock CA, Ghannoum MA.

Clin Microbiol Rev. 2005 Jan;18(1):163-94. Review.

8.

Disruption of the gene encoding the ChiB1 chitinase of Aspergillus fumigatus and characterization of a recombinant gene product.

Jaques AK, Fukamizo T, Hall D, Barton RC, Escott GM, Parkinson T, Hitchcock CA, Adams DJ.

Microbiology. 2003 Oct;149(Pt 10):2931-9.

PMID:
14523125
9.

Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.

Fukuoka T, Johnston DA, Winslow CA, de Groot MJ, Burt C, Hitchcock CA, Filler SG.

Antimicrob Agents Chemother. 2003 Apr;47(4):1213-9.

10.

Current and emerging azole antifungal agents.

Sheehan DJ, Hitchcock CA, Sibley CM.

Clin Microbiol Rev. 1999 Jan;12(1):40-79. Review.

11.

Mechanism of fluconazole resistance in Candida krusei.

Orozco AS, Higginbotham LM, Hitchcock CA, Parkinson T, Falconer D, Ibrahim AS, Ghannoum MA, Filler SG.

Antimicrob Agents Chemother. 1998 Oct;42(10):2645-9.

12.

The search for new triazole antifungal agents.

Koltin Y, Hitchcock CA.

Curr Opin Chem Biol. 1997 Aug;1(2):176-82. Review.

PMID:
9667858
13.
14.

Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.

Anaissie EJ, Paetznick VL, Ensign LG, Espinel-Ingroff A, Galgiani JN, Hitchcock CA, LaRocco M, Patterson T, Pfaller MA, Rex JH, Rinaldi MG.

Antimicrob Agents Chemother. 1996 Oct;40(10):2387-91.

15.

Increased cytochrome P-450 activity in Aspergillus fumigatus after xenobiotic exposure.

Baillie GS, Hitchcock CA, Burnet FR.

J Med Vet Mycol. 1996 Sep-Oct;34(5):341-7.

PMID:
8912168
16.
17.
18.

Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.

Geber A, Hitchcock CA, Swartz JE, Pullen FS, Marsden KE, Kwon-Chung KJ, Bennett JE.

Antimicrob Agents Chemother. 1995 Dec;39(12):2708-17.

19.

Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata.

Parkinson T, Falconer DJ, Hitchcock CA.

Antimicrob Agents Chemother. 1995 Aug;39(8):1696-9.

20.

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

Sugar AM, Hitchcock CA, Troke PF, Picard M.

Antimicrob Agents Chemother. 1995 Mar;39(3):598-601.

21.

The oncogenic potential of Candida in the female genital tract.

Lacey CJ, Dutton S, Smith RA, Walmsley RM, Wilkinson BM, Evans EG, Hitchcock CA, Adams DJ.

Int J Gynecol Cancer. 1995 Jan;5(1):8-14.

PMID:
11578446
22.

Fluconazole-insensitive OPC in AIDS patients.

Troke PF, Hitchcock CA.

J Infect. 1994 Mar;28(2):223-7. No abstract available.

PMID:
8080544
23.

Molecular approaches to identify novel targets for future development of antifungal agents.

Maresca B, Bennett J, Fonzi W, Hitchcock CA, Lodge JK, Williamson PR.

J Med Vet Mycol. 1994;32 Suppl 1:287-98. No abstract available.

PMID:
7722794
24.

Resistance of Candida albicans to azole antifungal agents.

Hitchcock CA.

Biochem Soc Trans. 1993 Nov;21(4):1039-47. Review. No abstract available.

PMID:
8131894
25.

Fluconazole resistance in Candida glabrata.

Hitchcock CA, Pye GW, Troke PF, Johnson EM, Warnock DW.

Antimicrob Agents Chemother. 1993 Sep;37(9):1962-5.

26.

Cytochrome P-450-dependent 14 alpha-sterol demethylase of Candida albicans and its interaction with azole antifungals.

Hitchcock CA.

Biochem Soc Trans. 1991 Aug;19(3):782-7. Review. No abstract available.

PMID:
1783216
27.

Microsomal chitinase activity from Candida albicans.

Dickinson K, Keer V, Hitchcock CA, Adams DJ.

Biochim Biophys Acta. 1991 Jan 23;1073(1):177-82.

PMID:
1991132
28.
29.

Purification and properties of cytochrome P-450-dependent 14 alpha-sterol demethylase from Candida albicans.

Hitchcock CA, Dickinson K, Brown SB, Evans EG, Adams DJ.

Biochem J. 1989 Oct 15;263(2):573-9.

30.
31.

Chitinase activity from Candida albicans and its inhibition by allosamidin.

Dickinson K, Keer V, Hitchcock CA, Adams DJ.

J Gen Microbiol. 1989 Jun;135(6):1417-21.

PMID:
2693599
32.

Cytochrome P-450-dependent 14 alpha-demethylation of lanosterol in Candida albicans.

Hitchcock CA, Brown SB, Evans EG, Adams DJ.

Biochem J. 1989 Jun 1;260(2):549-56.

33.

The identification of Candida albicans strains by restriction fragment length polymorphism analysis of DNA.

Smith RA, Hitchcock CA, Evans EG, Lacey CJ, Adams DJ.

J Med Vet Mycol. 1989;27(6):431-4.

PMID:
2576439
34.

Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.

Hitchcock CA, Barrett-Bee KJ, Russell NJ.

J Med Vet Mycol. 1987 Oct;25(5):329-33.

PMID:
3323450
35.

The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans.

Hitchcock CA, Barrett-Bee KJ, Russell NJ.

J Med Vet Mycol. 1987 Feb;25(1):29-37.

PMID:
3553525
36.

Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.

Hitchcock CA, Russell NJ, Barrett-Bee KJ.

Crit Rev Microbiol. 1987;15(1):111-5. Review.

PMID:
3319418
37.

The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans.

Hitchcock CA, Barrett-Bee KJ, Russell NJ.

J Gen Microbiol. 1986 Sep;132(9):2421-31.

PMID:
3540203

Supplemental Content

Loading ...
Support Center